Combined clinical end point analysis in all patients with MAPKBP1-associated kidney disease revealed a median age of 23 years and a mean age of 20.4 ± 1.8 years at KF (Figure 1cI and II, Supplementary Figure S2, Supplementary Table S3). This evidence concerns the gene MAPKBP1 and kidney disorder.